American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol. 2009 Apr 20; 27(12):2091-6.

View in: PubMed

subject areas

Adenocarcinoma
Antibodies, Monoclonal
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Colonic Neoplasms
ErbB Receptors
Humans
Mutation
Patient Selection
Proto-Oncogene Proteins
Proto-Oncogene Proteins p21(ras)
Randomized Controlled Trials as Topic
ras Proteins

authors with profiles

Richard Schilsky